Found 1263 clinical trials
Adolescent Asthma (12 to 17 year old)
A research study is now underway in the Miami area and is seeking participants with Asthma that are between 12 to 17 years old.
- 32 views
- 23 Nov, 2020
- 1 location
Facial Acne Study for Men or Women Ages 12 to 65. Compensation for time and travel may be up to $200.00
Facial Acne Study for Men or Women Ages 12 to 65. Compensation for time and travel may be up to $200.00
- 1228 views
- 08 Nov, 2020
- 1 location
A Phase 2, 12-week, double-blind, randomized, parallel group, placebo-controlled study of four doses of Study Medication in subjects with moderate to severe rheumatoid arthritis
A Phase 2, 12-week, double-blind, randomized, parallel group, placebo-controlled study of four doses of Study Medication in subjects with moderate to severe rheumatoid arthritis
- 290 views
- 08 Nov, 2020
- 1 location
Quit Smoking Study Ages 12 to 19 years
Quit Smoking Study Ages 12 to 19 years
- 799 views
- 08 Nov, 2020
- 1 location
CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.
CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.
- 144 views
- 08 Nov, 2020
- 1 location
If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.
If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.
- 252 views
- 23 Nov, 2020
- 1 location
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED
- 530 views
- 08 Nov, 2020
- 1 location
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).
- 570 views
- 08 Nov, 2020
- 1 location
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis
- 384 views
- 23 Nov, 2020
- 1 location
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
- 795 views
- 23 Nov, 2020
- 1 location